Senin, 05 Juni 2017

First-Line Abiraterone-ADT Combo for Hormone-Naïve PCa Ups Survival - Renal and Urology News


Telegraph.co.uk

First-Line Abiraterone-ADT Combo for Hormone-Naïve PCa Ups Survival
Renal and Urology News
CHICAGO—Adding abiraterone to androgen-deprivation therapy (ADT) as first-line treatment for advanced or high-risk prostate cancer (PCa) improves survival and delays disease progression compared with ADT alone, according to the findings of separate ...
Cutting Chemo Time in Low-Risk Colon Ca an OptionMedPage Today
Prostate cancer major breakthrough - drug trial brings hope for men 'worldwide'Express.co.uk
Much shorter chemo works for many colon cancer patients, study saysMinneapolis Star Tribune
Targeted Oncology -Medscape -News-Medical.net -The Hindu
all 99 news articles »


from Health - Google News http://ift.tt/2rW3SIS


EmoticonEmoticon